QCMC
HRTX icon

Quantum Capital Management (California)’s Heron Therapeutics HRTX Stock Holding History

Quantum Capital Management (California)’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-2,854
Closed -$42K – 252
2020
Q2 		$42K Hold
2,854
– – 0.02% 233
2020
Q1 		$34K Hold
2,854
– – 0.02% 245
2019
Q4 		$67K Hold
2,854
– – 0.03% 237
2019
Q3 		$53K Buy
+2,854
New +$52.5K 0.03% 253

Other funds holding HRTX

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Quantum Capital Management (California)'s HRTX Position: Q3 2020 in Review

Quantum Capital Management (California) sold out of Heron Therapeutics (HRTX) in Q3 2020, closing a stake of 2,854 shares — an estimated $42K sold.

Quantum Capital Management (California) first reported a position in HRTX in Q3 2019 and held it in 4 quarters. The position peaked at $67K in Q4 2019. 182 funds tracked by Wall St. Rank hold HRTX as of Q3 2020.

  • Quantum Capital Management (California) reported no remaining Heron Therapeutics position as of Q3 2020 after selling out during the quarter.
  • Quantum Capital Management (California) sold 2,854 Heron Therapeutics shares in Q3 2020, an estimated $42K.
  • Quantum Capital Management (California) first reported a position in Heron Therapeutics in Q3 2019 and held it in 4 quarters.
  • Quantum Capital Management (California)'s Heron Therapeutics position peaked at $67K in Q4 2019.
  • 182 funds tracked by Wall St. Rank held Heron Therapeutics as of Q3 2020.

Based on Quantum Capital Management (California)'s 13F filing for Q3 2020, filed 16 Nov 2020.